Firefly Neuroscience acquires Evoke Neuroscience to expand commercial footprint

Correction From Source: Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc. - Firefly Neuroscience (NASDAQ:AIFF)

A correction from source is being issued with respect to the press release titled, Firefly Neuroscience Achieves Multi-Fold Database, IP Portfolio, and Commercial Footprint Expansion Through Acquisition of Evoke Neuroscience, Inc., released on May 5, 2025 at 8:00 am ET. Please note, the correct form of payment of the potential Evoke investors' earn-out is in Firefly's common stock. The complete corrected press release follows: Builds upon Firefl…

Firefly Neuroscience acquires Evoke Neuroscience to expand commercial footprint

Firefly Neuroscience has completed the acquisition of Evoke Neuroscience, a developer of technologies aimed at assessing brain health.The post Firefly Neuroscience acquires Evoke Neuroscience to expand commercial footprint appeared first on Medical Device Network.

Firefly acquires Evoke Neuroscience—resulting in multi-fold database, IP portfolio, and commercial footprint expansion - BioTuesdays

Firefly Neuroscience (NASDAQ:AIFF) has announced its acquisition of closely held Evoke Neuroscience, a medical device company developing and commercializing technologies to aid in the comprehensive assessment of brain health. According to Firefly, the transaction—building on its recent acceptance into the NVIDIA Connect program—marks another important step toward its goal of developing a proprietary foundation model of the human brain. The acqui…